Empowered Funds
CRBU icon

Empowered Funds’s Caribou Biosciences CRBU Stock Holding History

Empowered Funds’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$131K Buy
+103,500
New +$162K ﹤0.01% 2375

Other funds holding CRBU

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Pfizer
Pfizer New York $164M AUM 53.62% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Empowered Funds's CRBU Position: Q3 2026 in Review

Empowered Funds opened a new position in Caribou Biosciences (CRBU) in Q3 2026: 103,500 shares worth $131K. The stake represents ﹤0.01% of the portfolio and ranks #2375 among its holdings.

109 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

  • Empowered Funds held 103,500 shares of Caribou Biosciences worth $131K as of Q3 2026.
  • Caribou Biosciences was a new Empowered Funds position in Q3 2026.
  • Caribou Biosciences made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2375 holding.
  • 109 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.